fatal familial insomnia
This disease is a subacute familial TSE, clinically characterized by intractable insomnia, autonomic dysfunction and motor signs that are unresponsive to treatment, and histopathologically characterized by selective atrophy of the anteroventral and dorsomedial nuclei of the thalamus. Earlier, this disease was confused with familial CJD. In 1986, Lugaresi et al. from the School of Medicine of the University of Bologna in Italy first reported and described the first case of this disease in detail, naming it fatal familial insomnia. Since then, a new member has been added to human prion diseases.
-
Site of disease:
Brain -
Infectious :
Not contagious -
Frequent population:
All groups -
Related symptoms:
Dysarthria Insomnia Ataxia Ataxia Dysarthria -
Concurrent disease:
Related Drugs
Zopiclone tablets
Indication: Insomnia. Especially suitable for patients who cannot tolerate the residual effect of the next morning.
Manufacturer:
Shanghai Sine Tianping Pharmaceutical Co., Ltd.
Zhenheling Tablets
Manufacturer:
Shanghai Lei Yun Shang Pharmaceutical Co., Ltd.
Zhenheling Tablets
Manufacturer:
Shanghai Lei Yun Shang Pharmaceutical Co., Ltd.
Ningshen Buxin Tablets
Manufacturer:
Luoyang Shunshi MEDICINE Industry Co., Ltd.
Brain-awakening and tranquilizing tablets
Manufacturer:
Dalian Merro Traditional Chinese Medicine Factory Co., Ltd.
Shen Kang Ning Wan
Manufacturer:
Wuxi Jiyu Shanhe Pharmaceutical Co., Ltd.
Anti-aging tablets
Manufacturer:
Chiatai Qingchunbao Pharmaceutical Co., Ltd.
Related Ingredients
-
Starch list
9005-25-8 -
Magnesium stearate list
557-04-0 -
Anise oil list
8007-70-3 -
Chrysophanic acid list
481-74-3 -
Mercury(II) sulfide list
1344-48-5